Unveiling Equifax (EFX) Q2 Outlook: Wall Street Estimates for Key Metrics

17.07.25 15:15 Uhr

Werte in diesem Artikel
Aktien

226,00 EUR -4,00 EUR -1,74%

78,50 EUR 1,00 EUR 1,29%

Indizes

6.297,4 PKT 33,7 PKT 0,54%

Wall Street analysts expect Equifax (EFX) to post quarterly earnings of $1.92 per share in its upcoming report, which indicates a year-over-year increase of 5.5%. Revenues are expected to be $1.51 billion, up 5.9% from the year-ago quarter.Over the last 30 days, there has been no revision in the consensus EPS estimate for the quarter. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of this timeframe.Ahead of a company's earnings disclosure, it is crucial to give due consideration to changes in earnings estimates. These revisions serve as a noteworthy factor in predicting potential investor reactions to the stock. Numerous empirical studies consistently demonstrate a strong relationship between trends in earnings estimate revision and the short-term price performance of a stock.While investors typically rely on consensus earnings and revenue estimates to gauge how the business may have fared during the quarter, examining analysts' projections for some of the company's key metrics often helps gain a deeper insight.That said, let's delve into the average estimates of some Equifax metrics that Wall Street analysts commonly model and monitor.The collective assessment of analysts points to an estimated 'Operating revenue- Workforce Solutions' of $652.84 million. The estimate suggests a change of +6.5% year over year.Analysts predict that the 'Operating revenue- Total International' will reach $350.25 million. The estimate indicates a change of +3.2% from the prior-year quarter.Analysts forecast 'Operating revenue- U.S. Information Solutions' to reach $509.88 million. The estimate indicates a year-over-year change of +6.6%.The combined assessment of analysts suggests that 'Operating revenue- U.S. Information Solutions- Financial Marketing Services' will likely reach $62.55 million. The estimate points to a change of +4.1% from the year-ago quarter.Analysts expect 'Operating revenue- Workforce Solutions- Verification Services' to come in at $558.35 million. The estimate suggests a change of +8.2% year over year.The consensus estimate for 'Operating revenue- U.S. Information Solutions- Online Information Solutions' stands at $443.97 million. The estimate indicates a year-over-year change of +17.5%.The consensus among analysts is that 'Operating revenue- Workforce Solutions- Employer Services' will reach $94.72 million. The estimate points to a change of -2.4% from the year-ago quarter.Based on the collective assessment of analysts, 'Operating revenue- Asia Pacific' should arrive at $86.43 million. The estimate indicates a change of +2.2% from the prior-year quarter.The average prediction of analysts places 'Operating revenue- Latin America' at $102.96 million. The estimate indicates a change of +5.8% from the prior-year quarter.It is projected by analysts that the 'Operating revenue- Europe' will reach $91.86 million. The estimate suggests a change of +4.2% year over year.Analysts' assessment points toward 'Operating revenue- Canada' reaching $69.40 million. The estimate indicates a year-over-year change of +0.3%.According to the collective judgment of analysts, 'Adjusted EBITDA- U.S. Information Solutions' should come in at $178.91 million. Compared to the current estimate, the company reported $158.60 million in the same quarter of the previous year. View all Key Company Metrics for Equifax here>>> Shares of Equifax have experienced a change of +2.3% in the past month compared to the +4.2% move of the Zacks S&P 500 composite. With a Zacks Rank #3 (Hold), EFX is expected to mirror the overall market performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .Zacks' Research Chief Picks Stock Most Likely to "At Least Double"Our experts have revealed their Top 5 recommendations with money-doubling potential – and Director of Research Sheraz Mian believes one is superior to the others. Of course, all our picks aren’t winners but this one could far surpass earlier recommendations like Hims & Hers Health, which shot up +209%.See Our Top Stock to Double (Plus 4 Runners Up) >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Equifax, Inc. (EFX): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: Equifax und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.

Ausgewählte Hebelprodukte auf Equifax

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Equifax

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Equifax Inc.

Wer­bung

Analysen zu Equifax Inc.

DatumRatingAnalyst
05.02.2019Equifax HoldDeutsche Bank AG
26.10.2018Equifax Equal WeightBarclays Capital
14.12.2017Equifax Equal WeightBarclays Capital
13.11.2017Equifax HoldStifel, Nicolaus & Co., Inc.
13.11.2017Equifax Sector PerformRBC Capital Markets
DatumRatingAnalyst
13.11.2017Equifax HoldStifel, Nicolaus & Co., Inc.
19.09.2017Equifax OutperformRBC Capital Markets
22.03.2017Equifax BuyStifel, Nicolaus & Co., Inc.
10.02.2017Equifax OverweightBarclays Capital
10.02.2017Equifax BuyStifel, Nicolaus & Co., Inc.
DatumRatingAnalyst
05.02.2019Equifax HoldDeutsche Bank AG
26.10.2018Equifax Equal WeightBarclays Capital
14.12.2017Equifax Equal WeightBarclays Capital
13.11.2017Equifax Sector PerformRBC Capital Markets
23.10.2017Equifax Sector PerformRBC Capital Markets
DatumRatingAnalyst

Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar.

Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Equifax Inc. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen